Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIHEXYPHENIDYL vs TRIMEPRAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRIHEXYPHENIDYL vs TRIMEPRAZINE: Safety Overview

Metric TRIHEXYPHENIDYL TRIMEPRAZINE
Total FAERS Reports 1,782 3,601
Deaths Reported 334 548
Death Rate 18.7% 15.2%
Hospitalizations 927 2,280
Average Patient Age 46.3 yrs 43.9 yrs
% Female Patients 35.8% 57.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Natco Pharma Limited N/A
Route ORAL N/A
Marketing Status Discontinued Discontinued